These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17527084)

  • 1. Low frequency of molecular changes and tumor recurrence in inverted papillomas of the urinary tract.
    Eiber M; van Oers JM; Zwarthoff EC; van der Kwast TH; Ulrich O; Helpap B; Stoerkel S; Blaszyk H; Cheville J; Sauter G; Wild PJ; Stoehr R; Hofstaedter F; Hartmann A
    Am J Surg Pathol; 2007 Jun; 31(6):938-46. PubMed ID: 17527084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger.
    Wild PJ; Giedl J; Stoehr R; Junker K; Boehm S; van Oers JM; Zwarthoff EC; Blaszyk H; Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI; Hartmann A
    J Pathol; 2007 Jan; 211(1):18-25. PubMed ID: 17072825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome].
    Giedl J; Wild PJ; Stoehr R; Junker K; Boehm S; van Oers JM; Zwarthoff EC; Blaszyk H; Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI; Hartmann A
    Verh Dtsch Ges Pathol; 2006; 90():253-63. PubMed ID: 17867604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
    Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?
    Cheville JC; Wu K; Sebo TJ; Cheng L; Riehle D; Lohse CM; Shane V
    Cancer; 2000 Feb; 88(3):632-6. PubMed ID: 10649258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis.
    Jones TD; Zhang S; Lopez-Beltran A; Eble JN; Sung MT; MacLennan GT; Montironi R; Tan PH; Zheng S; Baldridge LA; Cheng L
    Am J Surg Pathol; 2007 Dec; 31(12):1861-7. PubMed ID: 18043040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical and molecular review of inverted papilloma of the urinary tract: how to handle?
    Jørgensen PH; Vainer B; Hermann GG
    APMIS; 2015 Nov; 123(11):920-9. PubMed ID: 26358542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urothelial carcinoma of the upper urinary tract: inverted growth pattern is predictive of microsatellite instability.
    Hartmann A; Dietmaier W; Hofstädter F; Burgart LJ; Cheville JC; Blaszyk H
    Hum Pathol; 2003 Mar; 34(3):222-7. PubMed ID: 12673555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urine.
    van Rhijn BW; Lurkin I; Chopin DK; Kirkels WJ; Thiery JP; van der Kwast TH; Radvanyi F; Zwarthoff EC
    Clin Cancer Res; 2003 Jan; 9(1):257-63. PubMed ID: 12538478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.
    van Oers JM; Wild PJ; Burger M; Denzinger S; Stoehr R; Rosskopf E; Hofstaedter F; Steyerberg EW; Klinkhammer-Schalke M; Zwarthoff EC; van der Kwast TH; Hartmann A
    Eur Urol; 2007 Sep; 52(3):760-8. PubMed ID: 17240035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract].
    Burger M; Catto J; van Oers J; Zwarthoff E; Hamdy FC; Meuth M; Azzouri AR; Cussenot O; Wild PJ; Stoehr R; Hartmann A
    Verh Dtsch Ges Pathol; 2006; 90():244-52. PubMed ID: 17867603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome.
    van Rhijn BW; Vis AN; van der Kwast TH; Kirkels WJ; Radvanyi F; Ooms EC; Chopin DK; Boevé ER; Jöbsis AC; Zwarthoff EC
    J Clin Oncol; 2003 May; 21(10):1912-21. PubMed ID: 12743143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.
    Lindgren D; Liedberg F; Andersson A; Chebil G; Gudjonsson S; Borg A; Månsson W; Fioretos T; Höglund M
    Oncogene; 2006 Apr; 25(18):2685-96. PubMed ID: 16532037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis.
    Blaszyk H; Wang L; Dietmaier W; Hofstädter F; Burgart LJ; Cheville JC; Hartmann A
    Mod Pathol; 2002 Aug; 15(8):790-7. PubMed ID: 12181263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
    Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
    Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of urothelial inverted papilloma.
    Sung MT; Maclennan GT; Lopez-Beltran A; Montironi R; Cheng L
    Cancer; 2006 Dec; 107(11):2622-7. PubMed ID: 17078053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of chromosome 9 alterations as an initial step in urothelial carcinogenesis].
    Habuchi T; Kato T; Takahashi T; Ogawa O
    Hinyokika Kiyo; 2000 Oct; 46(10):749-55. PubMed ID: 11215205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological significance of TERT promoter mutation in papillary urothelial neoplasm of low malignant potential.
    Wang CC; Huang CY; Jhuang YL; Chen CC; Jeng YM
    Histopathology; 2018 Apr; 72(5):795-803. PubMed ID: 29193225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent FGFR3 mutations in urothelial papilloma.
    van Rhijn BW; Montironi R; Zwarthoff EC; Jöbsis AC; van der Kwast TH
    J Pathol; 2002 Oct; 198(2):245-51. PubMed ID: 12237885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.